Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm.
The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.
The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies.
UPDATED: The analysis comes in response to a proposed $1.5 billion term loan for RP, due in 2032, along with $800 million in secured notes and a $390 million revolving credit line.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.